("Jaguar" or the "Company") today announced the voting results of the Company's Special Meeting of Stockholders held on March 13, 2025 (the "Special Meeting"). Two proposals were submitted to and ...

Members of Napo's SAB are expected to join Jaguar representatives at the FDA meeting in the second quarter of 2025. As previously announced, the initial top line results from the OnTarget study ...

2025 Annual Meeting in Seattle, Washington. The authors include Pravin Chaturvedi, PhD, who is Jaguar's Chief Scientific Officer and Chair of Napo's Scientific Advisory Board, as well as leading ...